PDT Partners’s Zymeworks ZYME Stock Holding History

PDT Partners’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-110,673	Closed	-$725K	–	1182
2022 Q1	$725K	Buy	110,673 +13,252	+14%	+$118K	0.06%	473
2021 Q4	$1.6M	Buy	97,421 +19,708	+25%	+$411K	0.12%	270
2021 Q3	$2.26M	Buy	77,713 +20,922	+37%	+$696K	0.16%	233
2021 Q2	$1.97M	Sell	56,791 -24,527	-30%	-$778K	0.13%	271
2021 Q1	$2.57M	Buy	+81,318	New	+$3.3M	0.18%	230

Other funds holding ZYME

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

PDT Partners's ZYME Position: Q2 2022 in Review

PDT Partners sold out of Zymeworks (ZYME) in Q2 2022, closing a stake of 110,673 shares — an estimated $725K sold.

PDT Partners first reported a position in ZYME in Q1 2021 and held it in 5 quarters. The position peaked at $2.57M in Q1 2021. 113 funds tracked by Wall St. Rank hold ZYME as of Q2 2022.

PDT Partners reported no remaining Zymeworks position as of Q2 2022 after selling out during the quarter.
PDT Partners sold 110,673 Zymeworks shares in Q2 2022, an estimated $725K.
PDT Partners first reported a position in Zymeworks in Q1 2021 and held it in 5 quarters.
PDT Partners's Zymeworks position peaked at $2.57M in Q1 2021.
113 funds tracked by Wall St. Rank held Zymeworks as of Q2 2022.

Based on PDT Partners's 13F filing for Q2 2022, filed 15 Aug 2022.